Vita en Lag Estacion

The
n e w e ng l a n d j o u r na l
of
m e dic i n e
original article
Maternal Vitamin A Supplementation and Lung Function in Offspring

William Checkley, M.D., Ph.D., Keith P. West, Jr., Dr.P.H., Robert A. Wise, M.D., Matthew R. Baldwin, M.D., Lee Wu, M.H.S., Steven C. LeClerq, M.H.S., Parul Christian, Dr.P.H., Joanne Katz, Sc.D., James M. Tielsch, Ph.D., Subarna Khatry, M.D., and Alfred Sommer, M.D., M.H.S.
A bs t r ac t
Background
From the Division of Pulmonary and Critical Care, School of Medicine (W.C., R.A.W., M.R.B.), the Program in Global Disease Epidemiology and Control (W.C., J.K., J.M.T.) and the Center for Human Nutrition (K.P.W., L.W., S.C.L., P.C., J.K., J.M.T.), Department of International Health, and the Department of Epidemiology (A.S.), Bloomberg School of Public Health, Johns Hopkins University, Baltimore; and the Nepal Nutrition Intervention Project Sarlahi, National Society for the Prevention of Blindness, Kathmandu, Nepal (S.C.L., S.K.). Address reprint requests to Dr. Checkley at Johns Hopkins University School of Medicine, Division of Pulmonary and Critical Care, 1830 Monument St., 5th Fl., Baltimore, MD 21205, or at wcheckl1@jhmi.edu. This article (10.1056/NEJMoa0907441) was last updated on December 29, 2010, at NEJM.org. N Engl J Med 2010;362:1784-94.
Copyright 2010 Massachusetts Medical Society.
Vitamin A is important in regulating early lung development and alveolar formation. Maternal vitamin A status may be an important determinant of embryonic alveolar formation, and vitamin A deficiency in a mother during pregnancy could have lasting adverse effects on the lung health of her offspring. We tested this hypothesis by examining the long-term effects of supplementation with vitamin A or beta carotene in women before, during, and after pregnancy on the lung function of their offspring, in a population with chronic vitamin A deficiency.
Methods
We examined a cohort of rural Nepali children 9 to 13 years of age whose mothers had participated in a placebo-controlled, double-blind, cluster-randomized trial of vitamin A or beta-carotene supplementation between 1994 and 1997.
Results
Of 1894 children who were alive at the end of the original trial, 1658 (88%) were eligible to participate in the follow-up trial. We performed spirometry in 1371 of the children (83% of those eligible) between October 2006 and March 2008. Children whose mothers had received vitamin A had a forced expiratory volume in 1 second (FEV1) and a forced vital capacity (FVC) that were significantly higher than those of children whose mothers had received placebo (FEV1, 46 ml higher with vitamin A; 95% confidence interval [CI], 6 to 86; FVC, 46 ml higher with vitamin A; 95% CI, 8 to 84), after adjustment for height, age, sex, body-mass index, calendar month, caste, and individual spirometer used. Children whose mothers had received beta carotene had adjusted FEV1 and FVC values that were similar to those of children whose mothers had received placebo (FEV1, 14 ml higher with beta carotene; 95% CI, 24 to 54; FVC, 17 ml higher with beta carotene, 95% CI, 21 to 55).
Conclusions
In a chronically undernourished population, maternal repletion with vitamin A at recommended dietary levels before, during, and after pregnancy improved lung function in offspring. This public health benefit was apparent in the preadolescent years.
1784
n engl j med 362;19 nejm.org may 13, 2010
The New England Journal of Medicine Downloaded from nejm.org on June 16, 2011. For personal use only. No other uses without permission. Copyright 2010 Massachusetts Medical Society. All rights reserved.
itamin A deficiency affects 190 million preschool-aged children and 19 million pregnant women worldwide.1 It is the underlying cause of 650,000 early childhood deaths2 and has become recognized as an important problem among women of reproductive age in many developing countries. Chronic vitamin A deficiency may increase the risks of complications and death during pregnancy and in the postpartum period3-9 and, on the basis of evidence from studies in animals, may also adversely affect the embryonic and postnatal development of the offspring.10-14 The importance of vitamin A in regulating growth through cell proliferation and differentiation was recognized early in the 20th century.10-12 Results from animal research have since shown that vitamin A plays a key role in mediating fetal growth, morphogenesis, and maturation of multiple organ systems, including the respiratory system.14-20 Depletion of vitamin A from the diet of female rats before and during pregnancy is associated with agenesis or hypoplasia of the lungs in offspring, conditions that can be prevented with vitamin A supplementation in early, but not late, pregnancy.14 Furthermore, vitamin A depletion in pregnant rats has been associated with dosedependent decreases in DNA content in the lung tissue of their offspring.17,18 Since alveolarization begins in utero at about the 36th week of gestation,21 maternal vitamin A deficiency during pregnancy may have lasting effects on the lung maturation of progeny. Although results from studies in animals have shown that vitamin A is an important determinant of early lung development and size, data are lacking on the long-term consequences of vitamin A deficiency on lung health in human populations. We studied the effect of antenatal vitamin A supplementation on the lung function of preadolescent children in a chronically undernourished population in rural Nepal. The study cohort consisted of children, 9 to 13 years of age, whose mothers had participated in a randomized, placebo-controlled trial of vitamin A or beta-carotene supplementation before, during, and after pregnancy.
ern Nepal, in the densely populated, low-lying southern plains (Terai). The weather is usually warm and humid in this region, with temperatures exceeding 40C in the hot, dry season (April through June), followed by a season of monsoon rains (July through October), and thereafter by a cooler, dry season (November through March). The Terai is an area of chronic undernutrition and vitamin A deficiency.22,23 Rice is the staple of the diet. It is supplemented with small amounts of seasonal fruits, vegetables, lentil soup, and occasionally meat, fish, and eggs.
Original Vitamin A Trial
The original study, which was conducted between April 1994 and September 1997, was a doubleblind, placebo-controlled, cluster-randomized trial involving married women of childbearing age. The study was designed to determine the effects of weekly supplementation with a low dose of vitamin A or beta carotene on the rates of maternal death related to pregnancy.7 We invited all eligible women from 30 village development communities (VDCs) to participate in the trial. Each VDC is composed of 9 wards (for a total of 270 wards). The unit of block randomization was the ward, and each ward within a VDC was randomly assigned to one of the three study groups. A total of 44,646 women were enrolled and received weekly supplementation with 7000-g retinolequivalents of vitamin A, 7000-g retinol-equivalents of beta carotene, or placebo. Both supplements, as well as the placebo, were given in the form of gelatinous capsules taken orally. A total of 75% of the pregnant women received at least half the allowable dose (i.e., 50% of a dietary allowance in the case of those receiving vitamin A or beta carotene).7 We prospectively identified all pregnant women and followed the mothers and their infants for an assessment of vital status and health outcomes. Supplementation with vitamin A or beta carotene resulted in a reduction in the rates of maternal death related to pregnancy, from 704 per 100,000 pregnancies in the placebo group to 395 per 100,000 pregnancies in the combined vitamin Abeta-carotene groups (a 44% relative reduction with the supplements).7 Neither supplement had an effect on infant mortality.24 We enrolled a subgroup of pregnant women and Me thods their live-born infants from three VDCs (27 of the Study Setting 270 wards) in a substudy with a more detailed We conducted the original vitamin A trial and this protocol that involved interviews about illnesses, follow-up study in the Sarlahi District of south- diet, and other exposures; collection of blood
1785
The
of
m e dic i n e
samples at mid-pregnancy and at 3 months post partum; clinical examinations; and anthropometric measurements. Serum retinol levels, assessed in the women post partum and in their infants at 3 months of age, were higher in the vitamin A group than in the placebo group and were moderately higher in the beta-carotene group than in the placebo group.7,24 A total of 2055 children were born alive to mothers in the subsample who completed the pregnancy-to-postpartum dosing protocols. Of these children, 1894 (92%) were alive at the end of the trial (September 30, 1997).
Enrollment in the Follow-up Study
formed.25 Technicians reviewed with a supervisor all the flow-volume curves that were obtained each day. Flow-volume curves were transmitted weekly to Johns Hopkins University for additional review. Approximately every 3 months, we performed direct supervision and in-person review of all flowvolume curves with each technician.
Statistical Analysis
In 2006, we revisited the households of children whose mothers had participated in the original subsample study. Fieldworkers were unaware of the group assignments of the mothers in the original study. We used a household list derived from the original trial to generate an updated list of children who were eligible to participate in the follow-up study. Households in which the children were absent at the time of the visit were visited up to three times to maximize enrollment. The follow-up study was approved by the institutional review board at the Johns Hopkins University in Baltimore and at the Institute of Medicine, Tribhuvan University, in Kathmandu. We obtained oral or written informed consent from the mothers and assent from the children.
Spirometric Assessments
The objective of the follow-up trial was to determine whether there were differences in the forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) among children according to the group assignment of their mothers in the original trial. We used 20 SpiroPro (JAEGER) spirometers during the study period. SpiroPro is a lightweight, battery-operated, portable pneumo tachometer with factory-precalibrated pneumo tachometer tubes. We used only one pneumotach ometer tube per participant. During a 6-month period before the start of the study, we trained 11 technicians and 3 supervisors in the performance of spirometry. We numbered all our spirometers and asked technicians to use a different spirometer each day. Technicians visited the study children at their homes to perform spirometry. Each child underwent spirometry while in a sitting position and wearing a nose clip, until three acceptable and reproducible maneuvers, of a maximum of eight, had been per1786
The values for FEV1 and FVC were adjusted for height, age, sex, body-mass index, calendar month, and caste. Because biases can occur among different spirometers, we also adjusted for the specific spirometer that was used for the measurement. All analyses were performed according to the intention-to-treat principle. Because clustering by ward or VDC may have affected the estimation of standard errors, we used a linear mixed-effects model26 with two levels of random effects VDC and ward within VDC to account for the multilevel design of the trial. In subgroup analyses, we examined whether socioeconomic indicators or early exposures confounded the effects of the mothers original study-group assignment on lung function. In a subgroup of mothers in whom serum retinol levels or serum beta-carotene levels were measured post partum, we examined the relationship between the postpartum levels of these micronutrients in the mothers and the lung function of their preadolescent children. We compared proportions across study groups and according to enrollment status, using standard methods.27 P values of less than 0.05 were considered to indicate statistical significance. We used the R statistical package (www.r-project.org) for analyses.
R e sult s
Characteristics of the Study Population
The status of the 2055 live-born children from the original subsample is summarized in Figure 1. Of the 1894 children who were alive at the end of the original trial, 118 (6%) were no longer living in the study area at the time of the follow-up study, and 110 (6%) had died. No information was available for eight children (<1%). A total of 1658 children were eligible to participate, and 1371 (83% of those eligible) underwent spirometry between October 2006 and March 2008. We did not find significant differences between study groups in the mean proportions of children who died be-
5819 Women in 27 wards were recruited and underwent randomization
2031 Women (885 pregnancies) in 9 wards were assigned to receive beta carotene
1795 Women (771 pregnancies) in 9 wards were assigned to receive placebo
1993 Women (803 pregnancies) in 9 wards were assigned to receive vitamin A
738 Live-born children
57 Died on or before Sept. 30, 1997 43 Died after Sept. 30, 1997 46 Moved 1 Vital status unknown
591 Were living in study area at time of follow-up study
103 Could not be contacted 2 Status unknown 5 Declined
481 Underwent spirometry
Figure 1. Recruitment and Enrollment of Study Participants. There were 2055 live-born offspring of a well-defined subgroup of mothers from the original study of vitamin A supplementation, which was conducted between April 1994 and September 1997. A total of 1658 of those children were alive and living in the study area at the time of the follow-up study; 1371 of them underwent spirometry. Children were 9 to 13 years of age at the time they were enrolled in the follow-up study.
fore September 30, 1997 (P=0.09), children who died after September 30, 1997 (P=0.62), children who moved out of the study area (P=0.78), children who could not be contacted during the study period (P=0.99), or children who declined to participate or whose mothers did not want them to participate in the study (P=0.78). As compared with the 684 children from the original birth cohort who were not included in the follow-up study, children who were contacted and who underwent spirometry were less likely to be members of a low caste (P=0.003), less likely to live in a thatch or bamboo house (P<0.001), more likely to live in a household that owned land or livestock (P<0.001 for both comparisons), and more likely to have a father who was a farmer (P=0.04).
In 1322 (96%) of the 1371 children who underwent spirometry, the quality of the spirometry data met American Thoracic Society standards. We did not find significant differences between the study groups in demographic characteristics, anthropometric measurements, socioeconomic indicators, or early exposures (Table 1). We also did not find significant between-group differences in the age-adjusted mean height of the children (P=0.51) or in the proportion of children with a history of pneumonia during infancy (P=0.96).
Predictors of Lung Function
In an exploratory analysis, FEV1 and FVC were normally distributed. Height, sex, body-mass index,
1787
The
of
m e dic i n e
Table 1. Demographic, Anthropometric, and Socioeconomic Characteristics and Early Exposures among Children in Whom Adequate Spirometric Measurements Were Obtained, According to the Group Assignment of the Mothers.* Variable Maternal Study-Group Assignment Beta Carotene Sample size No. of wards No. of children No. of children per ward Median Range Demographic characteristics Age (yr) Overall mean Average of ward means Male sex (%) Overall mean Average of ward means Anthropometric measurements Height (cm) Overall mean Average of ward means Weight (kg) Overall mean Average of ward means Body-mass index Overall mean Average of ward means Socioeconomic status (average of ward proportions) Low caste Low-quality house Family owns land Family owns livestock Family owns radio Mother is literate Father is farmer Early exposures (% in ward) History of infantile pneumonia 7-day history of maternal tobacco use during pregnancy 64 25 67 27 63 26 0.93 0.96 86 89 60 85 32 21 50 92 95 66 82 28 10 53 83 92 62 90 30 17 46 0.65 0.22 0.72 0.32 0.67 0.17 0.61 14.71.4 14.70.4 14.41.1 14.60.5 14.41.3 14.50.6 0.73 25.14.3 25.21.3 24.83.8 25.31.4 24.74.0 25.11.7 0.97 130.47.3 130.62.0 130.87.2 131.51.8 130.97.1 131.31.8 0.62 55 55 48 48 51 51 0.10 11.10.77 11.10.21 11.20.75 11.30.21 11.20.75 11.10.19 0.17 45 2691 48 1678 37 11125 9 463 9 419 9 440 Placebo Vitamin A P Value
* Plusminus values are means SD. The average of ward means for specific variables was calculated by adding the group-specific ward means for that variable and dividing the sum by the number of group-specific wards. The body-mass index is the weight in kilograms divided by the square of the height in meters. Data in all categories of socioeconomic status were missing for 1 child in the beta carotene group, data on maternal literacy were missing for 183 children (59 in the beta carotene group, 54 in the placebo group, and 70 in the vitamin A group), and data on paternal occupation were missing for 189 children (62 in the beta carotene group, 55 in the placebo group, and 72 in the vitamin A group). Low-quality houses were those minimally constructed with either bamboo or thatch. Data on infant pneumonia were missing for 66 children (21 in the beta carotene group, 19 in the placebo group, and 26 in the vitamin A group), and data on the use of tobacco during the mothers pregnancy were missing for 123 children (44 in the beta carotene group, 44 in the placebo group, and 35 in the vitamin A group).
1788
A Unadjusted
1.8
B Adjusted
80 60
1.7
Residuals of FEV1 (ml) Beta Carotene Placebo Vitamin A
40 20 0 20 40
FEV1 (liters)
1.6
1.5
1.4
0.0
Beta Carotene
Placebo
Vitamin A
Figure 2. FEV1 in Children Whose Mothers Received Beta Carotene, Vitamin A, or Placebo before, during, and after Pregnancy. Results for forced expiratory volume in 1 second (FEV1) are shown for children 9 to 13 years of age whose mothers had been randomly assigned to receive supplementation with beta carotene, supplementation with vitamin A, or placebo before, during, and after pregnancy. Bars indicate wards; the wide bars indicate the wards that represent the median values. Unadjusted mean values of FEV1 in each ward within a village development community are shown in Panel A, according to the group assignment of the mothers (nine wards were randomly assigned to each group). Because of the variability in FEV1 according to the childrens anthropometric characteristics, we also show adjusted values of FEV1 (Panel B). We used a two-stage process to calculate adjusted values of FEV1. In the first stage, we used ordinary least squares to calculate the residuals of FEV1 regressed on height, age, sex, body-mass index, calendar month, caste, and spirometer. In the second stage, we calculated ward-level means of the residuals. We centered these ward-level summaries on the median value in the placebo group. Shown are the adjusted mean values of FEV1 for the nine wards in each study group.
calendar month, caste, and spirometer were significant predictors of FEV1 or FVC. We did not find significant differences in FEV1 or FVC according to the technician who performed the test or the pneumotachometer calibration code, nor did we find significant differences in FEV1 or FVC values over the course of the study.
Effects of Maternal Supplementation on the Lung Function of Offspring
The mean FEV1 and FVC in our study population were 1.54 liters and 1.74 liters, respectively. Children whose mothers had received vitamin A supplementation had higher values of FEV1 than children whose mothers had received placebo (Fig. 2). The FEV1 of children whose mothers had received vitamin A was, on average, 46 ml higher (95% confidence interval [CI], 6 to 86) than that of children whose mothers had received placebo, after adjustment for age, height, sex, body-mass index, caste, calendar month, and spirometer
(P=0.03). The adjusted FEV1 of children whose mothers had received beta carotene was, on average, 14 ml higher (95% CI, 24 to 54) than that of children whose mothers had received placebo (P=0.47). A similar comparison for FVC shows that children whose mothers had received vitamin A had higher values than children whose mothers had received placebo (Fig. 3). After adjustment for the same factors as those adjusted for in the FEV1 analysis, the FVC of children whose mothers had received vitamin A was 46 ml higher (95% CI, 8 to 84) than that of children whose mothers had received placebo (P=0.02). The adjusted FVC of children whose mothers had received beta carotene was 17 ml higher (95% CI, 21 to 55) than that of children whose mothers had received placebo (P=0.36). The effects of the mothers studygroup assignment on the lung function of the child was not confounded by the mothers socioeconomic status, the presence or absence of a his1789
The
of
m e dic i n e
A Unadjusted
2.2
B Adjusted
80 60 40 20 0 20
2.1
1.9
1.8
1.7 40 1.6 0.0
Beta Carotene
Placebo
Vitamin A
Residuals of FVC (ml)
2.0
FVC (liters)
Beta Carotene
Placebo
Vitamin A
Figure 3. FVC in Children Whose Mothers Received Beta Carotene, Vitamin A, or Placebo before, during, and after Pregnancy. Results for forced vital capacity (FVC) are shown for children 9 to 13 years of age whose mothers had been randomly assigned to receive supplementation with beta carotene, supplementation with vitamin A, or placebo before, during, and after pregnancy. Bars indicate wards; the wide bars indicate the wards that represent the median values. Unadjusted mean values of FVC in each ward within a village development community are shown in Panel A, according to the group assignment of the mothers (nine wards were randomly assigned to each group). Because of the variability in FVC according to the childrens anthropometric characteristics, we also show adjusted values of FVC (Panel B). We used a two-stage process to calculate adjusted values of FVC. In the first stage, we used ordinary least squares to calculate the residuals of FVC regressed on height, age, sex, body-mass index, calendar month, caste, and spirometer. In the second stage, we calculated ward-level means of the residuals. We centered these ward-level summaries on the median value in the placebo group. Shown are the adjusted mean values of FVC for the nine wards in each study group.
tory of pneumonia during the childs infancy, or the presence or absence of a 7-day history of tobacco use by the mother during her pregnancy (see the table in the Supplementary Appendix, available with the full text of this article at NEJM.org). We did not find significant between-group differences in the ratio of FEV1 to FVC (P=0.44), suggesting that lung size and airway caliber were influenced proportionally by maternal vitamin A supplementation.
Postpartum Serum Retinol Levels and Lung Function of Offspring
lated to the postpartum serum retinol levels of their mothers, after adjustment for height, bodymass index, age, sex, caste, calendar month, and spirometer (Fig. 4B and 4C). On average, FEV1 increased by 19 ml (95% CI, 3 to 35) and FVC increased by 16 ml (95% CI, 1 to 32) for every 1-SD increase in postpartum serum retinol level (1 SD = 0.510 mol per liter). Postpartum serum beta-carotene levels were measured in 594 mothers. We did not find a significant association between postpartum serum beta-carotene levels in the mothers and either FEV1 or FVC in their children.
We measured postpartum serum retinol levels in 678 mothers. Supplementation with vitamin A or beta carotene was associated with significantly higher serum retinol levels post partum (Fig. 4A). Without consideration of the mothers original group assignments, we found that the FEV1 and FVC levels of the study children were linearly re1790
Discussion
In a population with chronic vitamin A deficiency, maternal supplementation with vitamin A at recommended dietary levels before, during, and after pregnancy resulted in improved lung function in the offspring 9 to 13 years later. Improve-
Figure 4. Association between Maternal Postpartum Levels of Serum Retinol and Lung Function in Offspring. Shown are maternal postpartum levels of serum retinol and their association with forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) in the offspring 9 to 13 years later. Box plots of maternal serum retinol levels, according to maternal group assignment, are shown in Panel A. The lower and upper bounds of the boxes represent the 25th and 75th percentiles, respectively, and the heavy horizontal lines represent means. The I bars represent 1.5 times the interquartile range outside the 25th and 75th percentiles. The open circles represent values outside the I bars. Panel B shows a smoothing spline fit (solid line) and corresponding 95% confidence band (dashed lines) of the association between postpartum serum retinol levels in the mothers and FEV1 in their offspring, as estimated from a generalized additive model after adjustment for height, age, sex, body-mass index, caste, calendar month, and spirometer. The notches on the x axis represent the distribution of values for postpartum retinol. Panel C shows a smoothing spline fit (solid line) and corresponding 95% confidence band (dashed lines) of the association between postpartum serum retinol levels in the mothers and FVC in their offspring, as estimated from a generalized additive model after ad justment for height, age, sex, body-mass index, caste, calendar month, and spirometer. The notches on the x axis represent the distribution of values for postpartum retinol.
A
2.5
Postpartum Retinol (mol/liter)
1.5
0.5
0.0
Beta Carotene (N=244)
Placebo (N=201)
Vitamin A (N=233)
B
Postpartum Retinol Component of Estimated FEV1 (liters)
0.1
0.0
0.1 0.5 1.0 1.5 2.0 2.5
ment in lung function was probably due to supplementation received in utero because this population of children was subsequently exposed starting at 6 months of age and extending through their preschool years to high-coverage, semiannual vitamin A supplementation as part of a national program.28 The benefit from maternal supplementation with vitamin A was limited to children whose mothers received preformed vitamin A and was not seen in those whose mothers received beta carotene, possibly because beta carotene is a less efficient source of vitamin A than the preformed ester.29-31 We previously reported that supplementation with preformed vitamin A, but not beta carotene, corrected abnormal dark-adaptation thresholds in pregnant and lactating women32 and reduced the rate of death among infants born to mothers with night blindness.33 The greater bioefficacy of preformed vitamin A as compared with beta carotene may stem from differences in absorption and metabolism. In the gut, the preformed ester is hydrolyzed to retinol and efficiently absorbed, re-esterified, and delivered through circulating chylomicrons to the
Postpartum Retinol Component of Estimated FVC (liters)
0.1
0.0
0.1 0.5 1.0 1.5 2.0 2.5
liver for storage, although extrahepatic pathways for tissue delivery of vitamin A also exist.34 Once hepatic retinol is bound to retinol binding protein, it is released into the circulation to meet tissue needs, including those of the placenta and the developing fetus.35 On the other hand, beta carotene is less well absorbed than the preformed ester and must be cleaved and hydrolyzed to retinol in the intestines before becoming available as vitamin A.29 Beta carotene can also be directly absorbed and may be converted to vitamin A in tissues other than the intestine,31 including the
1791
The
of
m e dic i n e
maternalplacental interface.35 The lower bioefficacy of the beta-carotene supplement as a source of vitamin A in the mothers and their offspring in our trial was also evident in the finding that serum retinol concentrations in mothers at midpregnancy and post partum7 and in their infants at 3 months of age24 were lower among those in the beta-carotene group than they were among those in the preformedvitamin A group. There is a wealth of data from studies in animals13,20,36,37 and from observational studies involving children38,39 and adults40-43 suggesting that there is a positive functional relationship between vitamin A status and lung function. Studies have shown that defects in pulmonary development such as bronchopulmonary dysplasia may be linked to vitamin A deficiency.44,45 Vitamin A mediates alveolar formation and septation through the binding of its active metabolite, retinoic acid, to nuclear receptors.21 Thus, conditions that lead to vitamin A deficiency, to deletions in nuclear receptors for retinoic acid, or to improper signaling of these receptors have been associated with abnormalities in lung development.13,14,21 In animals, prenatal vitamin A supplementation after induced maternal deficiency prevents abnormal lung development in offspring.14 Postnatal treatment with retinoic acid, even in the presence of inhibitors of alveolar formation, induces alveolarization.20,37 However, retinoic acid is an intracellular metabolic intermediate of retinol, and unlike naturally occurring retinoids such as preformed vitamin A, it is not available as a supplement for common use. Our study provides data from a cohort of children in an undernourished population whose mothers were assigned at random to receive antenatal vitamin A supplementation or placebo. We controlled for potential imbalances that may have resulted from incomplete follow-up, since not all of the 2055 children who were born alive to the subsample of women enrolled in the original trial were available for study. The absence of confounders or imbalances across maternal supplement groups in predictors of lung function strengthens the likelihood that the observed association between maternal vitamin A supplementation and increased lung function in offspring was causal. Data regarding nutrition from birth to the time lung function was measured, retinol levels at the time lung function was measured, and the history with respect to pneumonia after infancy were not available.
1792
The effects of enhanced vitamin A status early in human life extend beyond the pulmonary system. Vitamin A supplementation in early childhood prevents xerophthalmia, a condition attributable to keratinization and necrosis of the corneal epithelium.46 Routine administration of vitamin A strengthens host defenses against infection, which can favor child survival in undernourished populations.46 Randomized trials in Indonesia, India, and Bangladesh showed that oral supplementation with 50,000 IU of vitamin A in oil shortly after birth reduced the rates of death during the first year of life by 64%,47 23%,48 and 16%,49 respectively. At sites in which specific causes of death were analyzed, the largest reductions were in diarrhea-related deaths.50 It is important to recognize that a mean increase of 46 ml in FEV1 (3% of the mean FEV1 in this study population) and in FVC (3% of the mean FVC) corresponds to a change in the distribution of values in this study population of children and does not predict the level of benefit that is expected in an individual child. However, the magnitude of the effect observed in this study is slightly greater than that associated with preventing exposure to parental smoking in schoolaged children.51 Because FEV1 correlates with overall longevity in the general adult population,52-54 any improvement in the distribution of values of FEV1 in a population may provide longterm health benefits. In summary, in an area in which there was chronic vitamin A deficiency, maternal supplementation with vitamin A before, during, and after pregnancy was a critical determinant of lung maturation among offspring 9 to 13 years later. Early interventions involving vitamin A supplementation in communities where undernutrition is highly prevalent may have long-lasting consequences for lung health.
Supported by a grant (no. 614) from the Bill and Melinda Gates Foundation and by a grant from the Sight and Life Research Institute, Baltimore. The original maternal vitamin A or beta-carotene supplementation trial (19941997) was conducted under the Vitamin A for Health Cooperative Agreement (HRN-A-0097-00015-00) between Johns Hopkins University and the Office of Health, Infectious Diseases and Nutrition of the U.S. Agency for International Development, with additional support from Task Force Sight and Life, Basel, Switzerland. Dr. Checkley is the recipient of a Clinician Scientist Award from Johns Hopkins University and a K99/R00 Pathway to Independence Award (K99HL096955) from the National Heart, Lung, and Blood Institute, National Institutes of Health. No potential conflict of interest relevant to this article was reported. We are grateful for the dedicated contributions of Sharada Ram Shrestha (deceased) to the field study.

References
1. Global prevalence of vitamin A defi-
ciency in populations at risk 19952005: WHO global database on vitamin A deficiency. Geneva: World Health Organization, 2009. 2. Rice AL, West KP Jr, Black RE. Vitamin A deficiency. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Vol. 1. Geneva: World Health Organization, 2004:211-56. 3. Christian P, West KP Jr, Khatry SK, et al. Night blindness of pregnancy in rural Nepal nutritional and health risks. Int J Epidemiol 1998;27:231-7. 4. Gorstein J, Shreshtra RK, Pandey S, Adhikari RK, Pradhan A. Current status of vitamin A deficiency and the National Vitamin A Control Program in Nepal: results of the 1998 National Micronutrient Status Survey. Asia Pac J Clin Nutr 2003; 12:96-103. 5. Semba RD, de Pee S, Panagides D, Poly O, Bloem MW. Risk factors for nightblindness among women of childbearing age in Cambodia. Eur J Clin Nutr 2003; 57:1627-32. 6. Saunders C, do Carmo Leal M, Gomes MM, et al. Gestational nightblindness among women attending a public maternity hospital in Rio de Janeiro, Brazil. J Health Popul Nutr 2004;22:348-56. 7. West KP Jr, Katz J, Khatry SK, et al. Double blind, cluster randomised trial of low dose supplementation with vitamin A or -carotene on mortality related to pregnancy in Nepal. BMJ 1999;318:570-5. 8. Christian P, West KP Jr, Khatry SK, et al. Night blindness during pregnancy and subsequent mortality among women in Nepal: effects of vitamin A and beta-carotene supplementation. Am J Epidemiol 2000;152:542-7. 9. Tielsch JM, Rahmathullah L, Katz J, et al. Maternal night blindness during pregnancy is associated with low birthweight, morbidity, and poor growth in South India. J Nutr 2008;138:787-92. 10. McCollum EV, Davis M. The necessity of certain lipins in the diet during growth. J Biol Chem 1913;15:167-75. 11. Mori S. The changes in para-ocular glands which follow the administration of diets low in fat-soluble A: with notes of the effects of the same diets on the salivary glands and the mucosa of the larynx and trachea. Bull Johns Hopkins Hosp 1922;33:357-9. 12. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 1925;42:753-77. 13. Wilson JG, Roth CB, Warkany J. An analysis of the syndrome of malformations induced by maternal vitamin A deficiency: effects of restoration of vitamin A at various times during gestation. Am J Anat 1953;92:189-217. 14. Zile MH. Function of vitamin A in ver-
tebrate embryonic development. J Nutr 2001;131:705-8. 15. Clagett-Dame M, DeLuca HF. The role of vitamin A in mammalian reproduction and embryonic development. Annu Rev Nutr 2002;22:347-81. 16. Sharma HS, Mishra UK. Postnatal distribution of vitamin A in liver, lung, heart and brain of the rat in relation to maternal vitamin A status. Biol Neonate 1986;50:345-50. 17. Idem. Biochemical development of the rat lung: studies on cellular DNA, RNA and protein content in relation to maternal vitamin A status. Z Ernahrungswiss 1987;26:116-24. 18. Chytil F. Retinoids in lung development. FASEB J 1996;10:986-92. 19. Zachman RD. Role of vitamin A in lung development. J Nutr 1995;125:Suppl: 1634S-1638S. 20. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol 1996;270:L305-L310. 21. Galambos C, Demello DE. Regulation of alveologenesis: clinical implications of impaired growth. Pathology 2008;40:12440. 22. Brilliant LB, Pokhrel RP, Grasset NC, et al. Epidemiology of blindness in Nepal. Bull World Health Organ 1985;63:375-86. 23. Upadhyay MP, Gurung BJ, Pillai KK, Nepal BP. Xerophthalmia among Nepalese children. Am J Epidemiol 1985;121:71-7. 24. Katz J, West KP Jr, Khatry SK, et al. Maternal low-dose vitamin A or -carotene supplementation has no effect on fetal loss and early infant mortality: a randomized cluster trial in Nepal. Am J Clin Nutr 2000;71:1570-6. 25. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36. 26. Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. New York: Springer Verlag, 2000. 27. Hayes RJ, Moulton LH. Cluster randomised trials. Boca Raton, FL: Chapman & Hall/CRC Press, 2008:149-231. 28. Nepal Micronutrient Status Survey, 1998. Kathmandu, Nepal: Ministry of Health Child Health Division, 1998:54-66. 29. Barua AB. Absorption and conversion of a single oral dose of beta-carotene in corn oil to vitamin A in Sprague-Dawley rats with low reserve of vitamin A. Int J Vitam Nutr Res 2003;73:267-73. 30. Hickenbottom SJ, Follett JR, Lin Y, et al. Variability in conversion of beta-carotene to vitamin A in men as measured by using a double-tracer study design. Am J Clin Nutr 2002;75:900-7. 31. Wang XD, Krinsky NI. The bioconversion of beta-carotene into retinoids. Subcell Biochem 1998;30:159-80. 32. Congdon NG, Dreyfuss ML, Christian P, et al. Responsiveness of dark-adaptation threshold to vitamin A and -carotene
supplementation in pregnant and lactating women in Nepal. Am J Clin Nutr 2000;72:1004-9. 33. Christian P, West KP Jr, Khatry SK, et al. Maternal night blindness increases risk of mortality in the first 6 months of life among infants in Nepal. J Nutr 2001; 131:1510-2. 34. Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol 2006;66:606-30. 35. Dimenstein R, Trugo NMF, Donangelo CM, Trugo LC, Anastcio AS. Effect of subadequate maternal vitamin-A status on placental transfer of retinol and betacarotene to the human fetus. Biol Neonate 1996;69:230-4. [Erratum, Biol Neonate 1996;70:248.] 36. Dirami G, Massaro GD, Clerch LB, Ryan US, Reczek PR, Massaro D. Lung retinol storing cells synthesize and secrete retinoic acid, an inducer of alveolus formation. Am J Physiol Lung Cell Mol Physiol 2004;286:L249-L256. 37. Massaro GD, Massaro D. Retinoic acid treatment partially rescues failed septation in rats and in mice. Am J Physiol Lung Cell Mol Physiol 2000;278:L955-L960. 38. Gilliland FD, Berhane KT, Li YF, Gauderman WJ, McConnell R, Peters J. Childrens lung function and antioxidant vitamin, fruit, juice, and vegetable intake. Am J Epidemiol 2003;158:576-84. 39. Aird FK, Greene SA, Ogston SA, Macdonald TM, Mukhopadhyay S. Vitamin A and lung function in CF. J Cyst Fibros 2006;5:129-31. 40. Grievink L, Smit HA, Veer P, Brunekreef B, Kromhout D. Plasma concentrations of the antioxidants beta-carotene and alphatocopherol in relation to lung function. Eur J Clin Nutr 1999;53:813-7. 41. Grievink L, Smit HA, Ock MC, van t Veer P, Kromhout D. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax 1998;53:166-71. 42. Morabia A, Menkes MJ, Comstock GW, Tockman MS. Serum retinol and airway obstruction. Am J Epidemiol 1990;132: 77-82. 43. Biesalski HK, Stofft E. Biochemical, morphological, and functional aspects of systemic and local vitamin A deficiency in the respiratory tract. Ann N Y Acad Sci 1992;669:325-31. 44. Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987;111:269-77. 45. Pearson E, Bose C, Snidow T, et al. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. J Pediatr 1992;121:420-7. 46. Sommer A, West KP Jr. Vitamin A deficiency: health, survival, and vision. New York: Oxford University Press, 1996.
1793

47. Humphrey JH, Agoestina T, Wu L, et 50. Tielsch JM, Rahmathullah L, Thula53. Rodriguez BL, Masaki K, Burchfiel C,
al. Impact of neonatal vitamin A supplementation on infant morbidity and mortality. J Pediatr 1996;128:489-96. 48. Rahmathullah L, Tielsch JM, Thulasiraj RD, et al. Impact of supplementing newborn infants with vitamin A on early infant mortality: community based randomised trial in southern India. BMJ 2003; 327:254-9. 49. Klemm RD, Labrique AB, Christian P, et al. Newborn vitamin A supplementation reduced infant mortality in rural Bangladesh. Pediatrics 2008;122(1):e242-e250.
siraj RD, et al. Newborn vitamin A dosing reduces the case fatality but not incidence of common childhood morbidities in South India. J Nutr 2007;137:2470-4. 51. Cook DG, Strachan DP, Carey IM. Health effects of passive smoking. 9. Parental smoking and spirometric indices in children. Thorax 1998;53:884-93. 52. Beaty TH, Cohen BH, Newill CA, Menkes HA, Diamond EL, Chen CJ. Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol 1982; 116:102-13.
et al. Pulmonary function decline and 17year total mortality: the Honolulu Heart Program. Am J Epidemiol 1994;140:398408. 54. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711-5.
Copyright 2010 Massachusetts Medical Society.
receive immediate notification when a journal article is released early
To be notified when an article is released early on the Web and to receive the table of contents of the Journal by e-mail every Wednesday evening, sign up through our Web site at NEJM.org.
1794

Vita en Lag Estacion

Caricato da

Informazioni sul documento

Descrizione originale:

Copyright

Formati disponibili

Condividi questo documento

Condividi o incorpora il documento

Opzioni di condivisione

Hai trovato utile questo documento?

Questo contenuto è inappropriato?

Copyright:

Formati disponibili

Vita en Lag Estacion

Caricato da

Copyright:

Formati disponibili

The

Maternal Vitamin A Supplementation and Lung Function in Offspring

n engl j med 362;19 nejm.org may 13, 2010

Maternal Vitamin A Supplementation and Lung Function in Offspring

n engl j med 362;19 nejm.org may 13, 2010

Maternal Vitamin A Supplementation and Lung Function in Offspring

5819 Women in 27 wards were recruited and underwent randomization

1795 Women (771 pregnancies) in 9 wards were assigned to receive placebo

1993 Women (803 pregnancies) in 9 wards were assigned to receive vitamin A

738 Live-born children

635 Live-born children

682 Live-born children

591 Were living in study area at time of follow-up study

506 Were living in study area at time of follow-up study

561 Were living in study area at time of follow-up study

103 Could not be contacted 2 Status unknown 5 Declined

63 Could not be contacted 10 Status unknown 7 Declined

72 Could not be contacted 20 Status unknown 5 Declined

481 Underwent spirometry

426 Underwent spirometry

464 Underwent spirometry

n engl j med 362;19 nejm.org may 13, 2010

n engl j med 362;19 nejm.org may 13, 2010

Maternal Vitamin A Supplementation and Lung Function in Offspring

Residuals of FEV1 (ml) Beta Carotene Placebo Vitamin A

n engl j med 362;19 nejm.org may 13, 2010

1.7 40 1.6 0.0

Residuals of FVC (ml)

n engl j med 362;19 nejm.org may 13, 2010

Maternal Vitamin A Supplementation and Lung Function in Offspring

Postpartum Retinol (mol/liter)

Beta Carotene (N=244)

0.1 0.5 1.0 1.5 2.0 2.5

Postpartum Retinol (mol/liter)

Postpartum Retinol Component of Estimated FVC (liters)

0.1 0.5 1.0 1.5 2.0 2.5

Postpartum Retinol (mol/liter)

n engl j med 362;19 nejm.org may 13, 2010

n engl j med 362;19 nejm.org may 13, 2010

Maternal Vitamin A Supplementation and Lung Function in Offspring

n engl j med 362;19 nejm.org may 13, 2010

Maternal Vitamin A Supplementation and Lung Function in Offspring

receive immediate notification when a journal article is released early

n engl j med 362;19 nejm.org may 13, 2010

Potrebbero piacerti anche